XML 45 R36.htm IDEA: XBRL DOCUMENT v3.23.2
NET INCOME (LOSS) PER COMMON SHARE (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Nov. 30, 2022
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Numerator [Abstract]              
Net income   $ 17,250 $ (109) $ 259 $ 272 $ 17,141 $ 532
Less: preferred stock dividend   0   (304)   0 (608)
Net income (loss) allocated to common stockholders   $ 17,250   $ (45)   $ 17,141 $ (76)
Denominator [Abstract]              
Weighted average common shares outstanding (in shares)   30,140,221   25,962,617   30,090,113 25,842,456
Basic income (loss) per share (in dollars per share)   $ 0.57   $ 0   $ 0.57 $ 0
Denominator [Abstract]              
Diluted shares outstanding (in shares)   30,397,308   25,962,617   30,333,495 25,842,456
Diluted income (loss) per share (in dollars per share)   $ 0.57   $ 0   $ 0.57 $ 0
Antidilutive Shares [Abstract]              
Antidilutive shares excluded from computation of loss per share (in shares)   0   6,928,480   0 6,981,247
Common Stock [Member]              
Preferred Stock [Abstract]              
Number of shares issued upon conversion of preferred stock (in shares) 423,729            
Stock conversion (in shares) 5,381,356            
Series A Convertible Preferred Stock [Member]              
Preferred Stock [Abstract]              
Preferred stock, par value (in dollars per share) $ 0            
Preferred stock, outstanding (in shares) 0            
Shares converted (in shares) (12,700)            
Series A Preferred Stock [Member]              
Antidilutive Shares [Abstract]              
Antidilutive shares excluded from computation of loss per share (in shares)   0   5,381,356   0 5,381,356
Unvested Restricted Stock [Member]              
Antidilutive Shares [Abstract]              
Antidilutive shares excluded from computation of loss per share (in shares)   0   1,547,124   0 1,599,891